The US Drug Enforcement Administration (DEA) is focusing on the wrong metrics by restricting the use of opioid pain medications and prosecuting doctors over the potential risk of drug diversion, says L. Joseph Parker. He argues that this approach has contributed to patient deaths and forced many to seek pain relief from unofficial sources, including counterfeit pills containing fentanyl. Parker calls for medical personnel, rather than law enforcement, to determine medication quotas.
Agentic AI could be a blessing and a curse for cybersecurity
Malwarebytes research shows that as agentic AI systems advance, they could become a significant tool for cybercriminals. This technology has the potential to be a
